sabirnetug
ACU193-201
Phase 2 small_molecule active
Quick answer
sabirnetug for Alzheimer Disease is a Phase 2 program (small_molecule) at Acumen Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acumen Pharmaceuticals
- Indication
- Alzheimer Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active